Paper Details

  1. Home
  2. Paper Details

An Update on Semaglutide Research: A Bibliometric Analysis and a Literature Review.

Author: AhmadRahnuma, DagliNamrata, HaqueMainul, KumarSantosh, NarwariaMahendra

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This study analyzed the most relevant authors, sources, keywords, and trends in recent and highly cited research papers on semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA). The most relevant authors were Chen and Zhang for recent papers, and Lingvay and Khunti for highly cited papers. The most common keywords were semaglutide, obesity, diabetes mellitus type 2, glucagon-like peptide-1, and cardiovascular disease (CVD). The most relevant source was 'Diabetes, Obesity and Metabolism'.
Paper Details　
Original Abstract of the Article :
This study analyzes the most relevant authors, sources, cooccurrence of keywords, thematic map, and trend topics of the most recent and most cited research papers on semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA). Also, the content of the 25 most cited papers is summarized. A tot...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552354/

データ提供：米国国立医学図書館（NLM）

Semaglutide: A Rising Star in Diabetes and Obesity Management

The fight against diabetes and obesity continues, with ongoing research seeking new and effective therapies. This study delves into the world of semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), analyzing its research landscape and highlighting its potential in managing these complex conditions. The researchers conducted a comprehensive bibliometric analysis and a literature review, exploring the most recent and influential research on semaglutide. The study offers valuable insights into the growing body of knowledge surrounding this promising therapeutic agent.

Semaglutide: A Versatile Weapon in the Arsenal

The analysis reveals a surge in research on semaglutide, with a growing body of evidence supporting its efficacy in managing type 2 diabetes mellitus (T2DM) and obesity. The researchers identified a significant number of studies exploring semaglutide's effectiveness in weight management, highlighting its potential as a valuable tool for tackling the global obesity epidemic. The analysis also highlighted the potential benefits of semaglutide in managing cardiovascular disease (CVD), suggesting its potential to address multiple health challenges.

Unlocking the Potential of GLP-1 RAs: A New Era in Diabetes and Obesity Management

This study provides a comprehensive overview of the research landscape surrounding semaglutide, highlighting its potential benefits and areas for further investigation. The findings emphasize the importance of continued research to further explore the therapeutic applications of semaglutide and its role in addressing the global burden of diabetes and obesity.

Dr.Camel's Conclusion

Semaglutide emerges as a beacon of hope in the fight against diabetes and obesity. Like a camel adapting to the harsh desert environment, semaglutide offers a promising solution for managing these complex conditions, contributing to a healthier future for individuals facing these challenges.

Date :
  1. Date Completed n.d.
  2. Date Revised 2023-10-31
Further Info :

Pubmed ID

37808605

DOI: Digital Object Identifier

PMC10552354

Related Literature

Article Analysis
・Side Effects of semaglutide
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.